Explore / Peer-reviewed article
Peer-reviewed articleOpen access

Effects of the Different Doses of Esketamine on Postoperative Quality of Recovery in Patients Undergoing Modified Radical Mastectomy: A Randomized, Double-Blind, Controlled Trial.

Zhu M, Xu S, Ju X, Wang S, Yu X

Drug design, development and therapyDec 16, 2022License: open accessChina49 citationsDOI: 10.2147/dddt.s392784

Abstract

<h4>Purpose</h4>This study aims to investigate the effects of the different doses of esketamine on postoperative quality of recovery in patients undergoing modified radical mastectomy.<h4>Methods</h4>Ninety-nine female patients were randomly allocated to three groups: the low-dose esketamine group (group E<sub>1</sub>) (0.5 mg/kg loading, 2 µg/kg/h infusion), the high-dose esketamine group (group E<sub>2</sub>) (0.5 mg/kg loading, 4 µg/kg/h infusion), the control group (group C) (received normal saline). The primary outcome was the quality of recovery-15 (QoR-15) scores on postoperative day 1 (POD1) and days 3 (POD3). The secondary outcomes were the sleep quality scores on POD1, bispectral index (BIS) value at 10, 30, and 60 min after operation, numeric rating scale (NRS) pain scores within 24 h after surgery, nausea, vomiting, drowsiness, nightmare, and intraoperative awareness.<h4>Results</h4>The total QoR-15 scores were higher in group E<sub>1</sub> and group E<sub>2</sub> than in group C on POD1 and POD3 (<i>P</i><0.05). The sleep quality scores on POD1 and BIS value at 10, 30, and 60 min after operation were higher in group E<sub>1</sub> and group E<sub>2</sub> than in group C (<i>P</i><0.05). The NRS pain scores at 2, 4 and 6 h after surgery in group E<sub>1</sub> and at 2, 4, 6, 12 and 24 h after surgery in group E<sub>2</sub> were lower than in group C (<i>P</i><0.05). The NRS pain scores at 6, 12 and 24 h after surgery in group E<sub>2</sub> were lower than in group E<sub>1</sub> (<i>P</i><0.05). The incidence of drowsiness was higher in group E<sub>1</sub> and group E<sub>2</sub> than in group C (<i>P</i><0.05).<h4>Conclusion</h4>Esketamine infusion improved to some extent the quality of recovery on POD1 and POD3 in patients undergoing modified radical mastectomy, especially 4 µg/kg/h esketamine was better, but the BIS value and incidence of drowsiness were significantly increased.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

KetaminePain

Keywords

Radical MastectomyEsketaminePostoperative Quality Of Recovery

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.

This study's objects

Directly linked records, matched by DOI, trial reference, or registry, not just topic.